1.
Prasad CB, Mahendru D, Dahiwal G, Gupta JB, Nellisserry JJ. Empagliflozin, Linagliptin, and Metformin in a triple fixed-dose combination for individuals with type 2 diabetes. Med. res. chronicles [Internet]. 2022Apr.13 [cited 2024Mar.29];9(2):99-106. Available from: https://medrech.com/index.php/medrech/article/view/569